Evidence map›Paper›PMID 42911484›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Purification of Nascent, Chromatin-Associated RNA Enriched for RNA Modifications.

Pavel Kudrin, Ulf Andersson Vang Ørom

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pavel KudrinInstitute of Biomedicine and Translational Medicine, University of Tartu,, Tartu, Estonia.
Ulf Andersson Vang ØromDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark. ulf.orom@mbg.au.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNAs that are being synthesized and remain tethered to chromatin during transcription are key participants in co-transcriptional gene regulation. They contribute to essential processes such as splicing, transcription elongation, and chromatin structure shaping. Co- and post-transcriptional RNA modifications have emerged as critical regulators of RNA metabolism and may modulate the function of chromatin-associated RNAs, including their interactions with chromatin. Here, we describe a method to isolate nascent, chromatin-associated RNA enriched for specific RNA modifications, using a combination of metabolic labeling, cell fractionation, and immunoprecipitation. This approach involves labeling of newly transcribed RNA with nucleotide analogs, followed by subcellular fractionation to enrich for chromatin-bound RNA species. Subsequently, immunoprecipitation with RNA modification-specific antibodies is used to selectively purify RNA bearing specific epitranscriptomic marks. We detail each component of the protocol, which can be adapted to various mammalian cell types and experimental conditions. The nature of this workflow enables investigation of RNA modifications on nascent, chromatin-associated transcripts under physiological or perturbed conditions, including various stimuli, genetic mutants, or disease-relevant cell lines.

Indexed as

ChromatinRNARNA Processing, Post-TranscriptionalAnimalsCell FractionationEpitranscriptomeHumansImmunoprecipitationTranscription, GeneticChromatinRNAChromatinNascent RNARNA modifications

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.